InterOcean Capital Group’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-10,000
Closed -$2.35M 263
2021
Q2
$2.35M Hold
10,000
0.12% 87
2021
Q1
$1.31M Buy
+10,000
New +$1.45M 0.07% 98

Other funds holding MRNA

InterOcean Capital Group's MRNA Position: Q3 2021 in Review

InterOcean Capital Group sold out of Moderna (MRNA) in Q3 2021, closing a stake of 10,000 shares — an estimated $2.35M sold.

InterOcean Capital Group first reported a position in MRNA in Q1 2021 and held it in 2 quarters. The position peaked at $2.35M in Q2 2021. 1,140 funds tracked by Wall St. Rank hold MRNA as of Q3 2021.

  • InterOcean Capital Group reported no remaining Moderna position as of Q3 2021 after selling out during the quarter.
  • InterOcean Capital Group sold 10,000 Moderna shares in Q3 2021, an estimated $2.35M.
  • InterOcean Capital Group first reported a position in Moderna in Q1 2021 and held it in 2 quarters.
  • InterOcean Capital Group's Moderna position peaked at $2.35M in Q2 2021.
  • 1,140 funds tracked by Wall St. Rank held Moderna as of Q3 2021.

Based on InterOcean Capital Group's 13F filing for Q3 2021, filed 8 Nov 2021.